Connect with us
https://tickernews.co/wp-content/uploads/2023/10/AmEx-Thought-Leaders.jpg

News

How Biniam Grimay’s historic victory celebration took an unpleasant turn

Published

on

Biniam Grimay finished stage 10 with a blazing sprint in a historic victory at Giro d’Italia

The 22- year old cyclist became the first Black African rider to win a grand tour stage

However, the celebration turned rather bitter as champagne cork struck his eye on the winner’s podium.

https://twitter.com/GcnRacing/status/1526592459609890816

Grimay was treated in the Ambulance after the celebrations.

He later missed the post-race interviews and was taken to the hospital for further care.

Grimay is now out of the Giro d’italia because of the eye injury.

 

Shreya Vats Contributed to the report

Continue Reading

News

Does American media have TikTok bias?

Published

on

While the fate of TikTok remains uncertain in the U.S.—there is no shortage of possibilities.

Euro Bloch is a comprehensive program designed to highlight the breadth of topics and issues within the EU political landscape. It offers insightful analysis within the evolving framework of relations between the European Union and Australia/Asia-Pacific region. Hosted by Natanael Bloch.

Next month’s EU elections are looming, with the far-right gaining traction. In this episode, Natanael is joined by Professor Bruce Wilson, Director of EU Centre of Excellence at RMIT University. #EURO BLOCH

Continue Reading

News

Will the U.S. approve MDMA therapy?

Published

on

MDMA is a drug commonly known as molly or ecstasy.

Some medical professionals say it can be helpful for people with post-traumatic stress disorder — which is why a group has been fighting to get MDMA legalized as a prescription drug.

Currently, the U.S. Food and Drug Administration is reviewing an application to use MDMA to treat PTSD. The agency is expected to announce its ruling as soon as August.

Anna Silman, a features correspondent with Business Insider joins Veronica Dudo to discuss. #IN AMERICA TODAY #trending #drugs #MDMA #MDMATherapy #business #pharmaceutical

Continue Reading

Trending Now